{"id":1028,"date":"2012-03-20T14:08:07","date_gmt":"2012-03-20T12:08:07","guid":{"rendered":"http:\/\/www.spa-balance.com\/?p=1028"},"modified":"2012-03-20T14:08:07","modified_gmt":"2012-03-20T12:08:07","slug":"la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas","status":"publish","type":"post","link":"https:\/\/www.spa-balance.com\/es\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/","title":{"rendered":"The Pharmaceutical Industry: A Business Opportunity for Spas?"},"content":{"rendered":"

<\/p>\n

 <\/p>\n

In previous posts, we have written about the current strain of national healthcare systems around the world, and the development of a synergy between spas and hospitals<\/a>. This time, we are focusing on a new synergy that our industry can forge with another important player of the health field: The pharmaceutical industry.<\/p>\n

This post explores the current scenario of the pharmaceutical industry and the approach this field is taking to deal with the challenges they are facing, which could ultimately create a new and interesting business opportunity for the spa industry. We firmly believe, all actors involved in health and wellbeing now need to see what they can do and offer in order to increase the quality of life of their consumers.<\/p>\n

<\/p>\n

 <\/p>\n

\u00a0<\/p>\n

En art\u00edculos anteriores nos hemos referido a la crisis actual de los sistemas nacionales de salud en todo el mundo as\u00ed como al desarrollo de una sinergia entre spas y hospitales<\/a>. En esta ocasi\u00f3n, nos enfocaremos en una nueva sinergia que nuestro sector puede desarrollar con otro protagonista importante dentro del campo de la salud: La industria farmac\u00e9utica.<\/p>\n

Este art\u00edculo explora el escenario actual de la industria farmac\u00e9utica y el enfoque que dicho campo est\u00e1 adoptando para hacer frente a los retos que enfrenta y que en \u00faltimas podr\u00eda terminar creando una oportunidad de negocios nueva e interesante para la industria del spa. Creemos firmemente que todos los actores involucrados en la salud y el bienestar de hoy en d\u00eda necesitan ver lo que pueden hacer y ofrecer con el fin de aumentar la calidad de vida de sus consumidores.<\/p>\n

<\/p>\n

 <\/p>\n

The Crisis of The Pharmaceutical Industry<\/strong><\/p>\n

Just like hospitals, the pharmaceutical industry is also facing its own crisis. According to \u2018Fight or Flight<\/a>,\u2019 a recent survey elaborated by Roland Berger Strategy Consultants, \u201c65% of the companies surveyed believe that the pharmaceutical industry is facing a strategic crisis\u201d. Stephan Danner, a pharmaceutical expert, states that this crisis is the result of \u201cpublic cost containment measures, difficult market access as well as massive patent expiries\u201d.<\/p>\n

Although the overall performance of the pharmaceutical industry is still strong, the 2011 CMR International Pharmaceutical R&D Factbook<\/a> highlights a significant decrease in the production of new drugs. Along those lines, the \u2018Fight or Flight\u2019 report states that over US$ 400 billion of market capitalisation has been \u201clost over the past 10 years among innovative pharma companies\u201d.<\/p>\n

In addition to this, big pharmaceutical companies still rely heavily on revenue generated by well established products, a serious risk considering that \u201cover the next three years (2012-2014) more than 110 products will lose patent exclusivity in the US\u2019\u2019. In other words, this means that \u201cmore than half of the industry’s sales going off-patent\u201d within this period of time. The financial crisis and pressures on lower drug prices are also creating additional problems for the industry\u2019s overall performance.<\/p>\n

 <\/p>\n

Focusing on Diversification<\/strong><\/p>\n

In this context, diversification has recently gained popularity within the pharmaceutical industry as an effective strategy to deal with the current crisis. According to the \u2018Fight or Flight\u2019 survey, \u201c67% of pharma executives see diversification as a potential way forward\u201d. Considering the lost market capitalisation we mentioned above, for the first time in history the financial community supports a strategy based on diversification for the pharmaceutical industry.<\/p>\n

The Roland Berger study identifies three dimensions of diversification: the de-risk path, the innovation path and the integration path. At the moment, the conservative de-risk path seems to be the favourite one among pharma companies. Along those lines, \u201c78% of executives perceive generics to be the most important area of diversification followed by consumer health (50%) and vaccines (42%)\u201d.<\/p>\n

 <\/p>\n

A Business Opportunity for The Spa Industry<\/strong><\/p>\n

As we have discussed, there is an imminent crisis affecting the pharmaceutical industry today. In spite of this, this field is already facing this crisis with a new strategy based on diversification. As stated by Wayne Schnarr, a healthcare consultant, in a previous post on the Cross-Border Bio Tech Blog<\/a>, \u201cExpansion and diversification could also involve other types of drug products and healthcare activities\u201d. The \u2018Fight or Flight\u2019 also states that in order to create value from diversification, pharmaceutical companies must leverage existing capabilities and forge new synergies.<\/p>\n

It is precisely from this new approach in the pharmaceutical field that the spa industry can develop a new business opportunity. A good step forward would be for spas, hospitals and pharmaceutical companies to join forces as all industries need to innovate and change their business strategies.<\/p>\n

<\/p>\n

 <\/p>\n

La crisis de la industria farmac\u00e9utica<\/strong><\/p>\n

<\/strong>Al igual que los hospitales, la industria farmac\u00e9utica tambi\u00e9n se enfrenta a su propia crisis. De acuerdo con \u2018Fight or Flight<\/a>\u2019, un estudio elaborado recientemente por Roland Berger Strategy Consultants, “el 65% de las empresas encuestadas creen que la industria farmac\u00e9utica se enfrenta a una crisis estrat\u00e9gica”. Stephan Danner, un experto en farmac\u00e9utica, afirma que esta crisis es el resultado de “medidas de contenci\u00f3n del gasto p\u00fablico, un acceso dif\u00edcil al mercado y vencimientos masivos de patentes”.<\/p>\n

Aunque el rendimiento global de la industria farmac\u00e9utica sigue siendo fuerte, el reporte 2011 CMR International Pharmaceutical R&D Factbook<\/a> pone de manifiesto una disminuci\u00f3n significativa en la producci\u00f3n de nuevos medicamentos. A este respecto, el estudio \u2018Fight or Flight\u2019 se\u00f1ala que m\u00e1s de US$400 billones en capitalizaci\u00f3n de mercado se han “perdido en los \u00faltimos 10 a\u00f1os entre las empresas farmac\u00e9uticas innovadoras”.<\/p>\n

Adem\u00e1s de esto, las grandes compa\u00f1\u00edas farmac\u00e9uticas siguen dependiendo en gran medida de los ingresos generados por productos bien establecidos, un riesgo grave si se considera que “en los pr\u00f3ximos tres a\u00f1os (2012-2014) m\u00e1s de 110 productos perder\u00e1n la exclusividad de patentes en los Estados Unidos”. En otras palabras, esto significa que “m\u00e1s de la mitad de las ventas de la industria perder\u00e1 su patente” dentro de este periodo de tiempo. La crisis financiera y las presiones para establecer precios m\u00e1s bajos para los medicamentos tambi\u00e9n est\u00e1n creando problemas adicionales en el rendimiento global de la industria.<\/p>\n

 <\/p>\n

Centr\u00e1ndose en la diversificaci\u00f3n<\/strong><\/p>\n

<\/strong>En este contexto, la diversificaci\u00f3n ha ganado recientemente popularidad dentro de la industria farmac\u00e9utica como una estrategia eficaz para hacer frente a la crisis actual. De acuerdo con \u2018Fight or Flight\u2019, \u201cel 67% de los ejecutivos farmac\u00e9uticos consideran la diversificaci\u00f3n como opci\u00f3n potencial hacia el futuro “. Teniendo en cuenta la p\u00e9rdida de capitalizaci\u00f3n de mercado que mencionamos antes, por primera vez en la historia la comunidad financiera est\u00e1 a favor de una estrategia para la industria farmac\u00e9utica basada en la diversificaci\u00f3n.<\/p>\n

El estudio de Roland Berger identifica tres dimensiones de la diversificaci\u00f3n: la opci\u00f3n de reducci\u00f3n del riesgo, la opci\u00f3n de la innovaci\u00f3n y la opci\u00f3n de la integraci\u00f3n. Por el momento, la conservadora opci\u00f3n de reducci\u00f3n del riesgo parece ser la alternativa favorita entre las compa\u00f1\u00edas farmac\u00e9uticas. En ese sentido, “el 78% de los ejecutivos ven en los medicamentos gen\u00e9ricos el \u00e1rea m\u00e1s importante de diversificaci\u00f3n seguida por la salud del consumidor (50%) y las vacunas (42%)”.<\/p>\n

 <\/p>\n

Una oportunidad de negocio para el sector del spa<\/strong><\/p>\n

Como ya hemos comentado, hay una crisis inminente que afecta a la industria farmac\u00e9utica de hoy en d\u00eda. A pesar de ello, este campo ya se enfrenta a esta crisis con una nueva estrategia basada en la diversificaci\u00f3n. Tal y como lo ha se\u00f1alado el consultor de salud Wayne Schnarr en un art\u00edculo publicado en el blog Cross-Border Bio Tech Blog<\/a>, “la expansi\u00f3n y la diversificaci\u00f3n tambi\u00e9n podr\u00edan incluir otros tipos de productos farmac\u00e9uticos y actividades de salud”. El estudio \u2018Fight or Flight\u2019 indica, adem\u00e1s, que las empresas farmac\u00e9uticas deben reforzar las capacidades existentes y forjar nuevas sinergias si quieren generar valor sobre la diversificaci\u00f3n.<\/p>\n

Es precisamente a partir de este nuevo enfoque en el campo farmac\u00e9utico que la industria del spa puede desarrollar una nueva oportunidad de negocios. Un buen paso hacia adelante ser\u00eda que los spas, hospitales y compa\u00f1\u00edas farmac\u00e9uticas pudieran unir sus fuerzas ya que todas estas industrias necesitan innovar y cambiar sus estrategias de negocio.<\/p>\n

<\/p>","protected":false},"excerpt":{"rendered":"

  In previous posts, we have written about the current strain of national healthcare systems around the world, and the development of a synergy between spas and hospitals. This time, we are focusing on a new synergy that our industry can forge with another important player of the health field: The pharmaceutical industry. This post […]<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3],"tags":[187,188,189,190,191,192,193,194,195,196],"class_list":["post-1028","post","type-post","status-publish","format-standard","hentry","category-other-spa-related-topics","tag-diversificacion","tag-diversification","tag-fight-or-flight","tag-industria-farmaceutica","tag-johnson-and-johnson","tag-novartis","tag-patentes","tag-patents","tag-pfizer","tag-pharmaceutical-industry"],"acf":[],"yoast_head":"\nThe Pharmaceutical Industry: A Business Opportunity for Spas? — Spa Balance<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.spa-balance.com\/es\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Pharmaceutical Industry: A Business Opportunity for Spas? — Spa Balance\" \/>\n<meta property=\"og:description\" content=\"  In previous posts, we have written about the current strain of national healthcare systems around the world, and the development of a synergy between spas and hospitals. This time, we are focusing on a new synergy that our industry can forge with another important player of the health field: The pharmaceutical industry. This post […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.spa-balance.com\/es\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/\" \/>\n<meta property=\"og:site_name\" content=\"Spa Balance\" \/>\n<meta property=\"article:published_time\" content=\"2012-03-20T12:08:07+00:00\" \/>\n<meta name=\"author\" content=\"Sonal Uberoi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sonal Uberoi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/2012\\\/03\\\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/2012\\\/03\\\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\\\/\"},\"author\":{\"name\":\"Sonal Uberoi\",\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/#\\\/schema\\\/person\\\/8e140ef4f1a16322c5ef0d258647f8b3\"},\"headline\":\"The Pharmaceutical Industry: A Business Opportunity for Spas?\",\"datePublished\":\"2012-03-20T12:08:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/2012\\\/03\\\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\\\/\"},\"wordCount\":1393,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/#organization\"},\"keywords\":[\"diversificacion\",\"diversification\",\"fight or flight\",\"industria farmaceutica\",\"johnson and johnson\",\"novartis\",\"patentes\",\"patents\",\"pfizer\",\"pharmaceutical industry\"],\"articleSection\":[\"Other Spa Related Topics\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/2012\\\/03\\\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\\\/\",\"url\":\"https:\\\/\\\/www.spa-balance.com\\\/2012\\\/03\\\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\\\/\",\"name\":\"The Pharmaceutical Industry: A Business Opportunity for Spas? — Spa Balance\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/#website\"},\"datePublished\":\"2012-03-20T12:08:07+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.spa-balance.com\\\/2012\\\/03\\\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/#website\",\"url\":\"https:\\\/\\\/www.spa-balance.com\\\/\",\"name\":\"Spa Balance\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.spa-balance.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/#organization\",\"name\":\"Spa Balance Consulting\",\"url\":\"https:\\\/\\\/www.spa-balance.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.spa-balance.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.spa-balance.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo.png\",\"width\":209,\"height\":75,\"caption\":\"Spa Balance Consulting\"},\"image\":{\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.spa-balance.com\\\/#\\\/schema\\\/person\\\/8e140ef4f1a16322c5ef0d258647f8b3\",\"name\":\"Sonal Uberoi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/i0.wp.com\\\/www.spa-balance.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/902B1583-cropped.jpg?fit=96%2C96&ssl=1\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.spa-balance.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/902B1583-cropped.jpg?fit=96%2C96&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.spa-balance.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/902B1583-cropped.jpg?fit=96%2C96&ssl=1\",\"caption\":\"Sonal Uberoi\"},\"url\":\"https:\\\/\\\/www.spa-balance.com\\\/es\\\/author\\\/sonal\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Pharmaceutical Industry: A Business Opportunity for Spas? — Spa Balance","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.spa-balance.com\/es\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/","og_locale":"es_ES","og_type":"article","og_title":"The Pharmaceutical Industry: A Business Opportunity for Spas? — Spa Balance","og_description":"  In previous posts, we have written about the current strain of national healthcare systems around the world, and the development of a synergy between spas and hospitals. This time, we are focusing on a new synergy that our industry can forge with another important player of the health field: The pharmaceutical industry. This post […]","og_url":"https:\/\/www.spa-balance.com\/es\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/","og_site_name":"Spa Balance","article_published_time":"2012-03-20T12:08:07+00:00","author":"Sonal Uberoi","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Sonal Uberoi","Tiempo de lectura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.spa-balance.com\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/#article","isPartOf":{"@id":"https:\/\/www.spa-balance.com\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/"},"author":{"name":"Sonal Uberoi","@id":"https:\/\/www.spa-balance.com\/#\/schema\/person\/8e140ef4f1a16322c5ef0d258647f8b3"},"headline":"The Pharmaceutical Industry: A Business Opportunity for Spas?","datePublished":"2012-03-20T12:08:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.spa-balance.com\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/"},"wordCount":1393,"commentCount":0,"publisher":{"@id":"https:\/\/www.spa-balance.com\/#organization"},"keywords":["diversificacion","diversification","fight or flight","industria farmaceutica","johnson and johnson","novartis","patentes","patents","pfizer","pharmaceutical industry"],"articleSection":["Other Spa Related Topics"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.spa-balance.com\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/","url":"https:\/\/www.spa-balance.com\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/","name":"The Pharmaceutical Industry: A Business Opportunity for Spas? — Spa Balance","isPartOf":{"@id":"https:\/\/www.spa-balance.com\/#website"},"datePublished":"2012-03-20T12:08:07+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.spa-balance.com\/2012\/03\/la-industria-farmaceutica-una-oportunidad-de-negocios-para-los-spas\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.spa-balance.com\/#website","url":"https:\/\/www.spa-balance.com\/","name":"Spa Balance","description":"","publisher":{"@id":"https:\/\/www.spa-balance.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.spa-balance.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.spa-balance.com\/#organization","name":"Spa Balance Consulting","url":"https:\/\/www.spa-balance.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.spa-balance.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.spa-balance.com\/wp-content\/uploads\/2021\/03\/logo.png","contentUrl":"https:\/\/www.spa-balance.com\/wp-content\/uploads\/2021\/03\/logo.png","width":209,"height":75,"caption":"Spa Balance Consulting"},"image":{"@id":"https:\/\/www.spa-balance.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.spa-balance.com\/#\/schema\/person\/8e140ef4f1a16322c5ef0d258647f8b3","name":"Sonal Uberoi","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/i0.wp.com\/www.spa-balance.com\/wp-content\/uploads\/2021\/03\/902B1583-cropped.jpg?fit=96%2C96&ssl=1","url":"https:\/\/i0.wp.com\/www.spa-balance.com\/wp-content\/uploads\/2021\/03\/902B1583-cropped.jpg?fit=96%2C96&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.spa-balance.com\/wp-content\/uploads\/2021\/03\/902B1583-cropped.jpg?fit=96%2C96&ssl=1","caption":"Sonal Uberoi"},"url":"https:\/\/www.spa-balance.com\/es\/author\/sonal\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.spa-balance.com\/es\/wp-json\/wp\/v2\/posts\/1028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.spa-balance.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.spa-balance.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.spa-balance.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.spa-balance.com\/es\/wp-json\/wp\/v2\/comments?post=1028"}],"version-history":[{"count":0,"href":"https:\/\/www.spa-balance.com\/es\/wp-json\/wp\/v2\/posts\/1028\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.spa-balance.com\/es\/wp-json\/wp\/v2\/media?parent=1028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.spa-balance.com\/es\/wp-json\/wp\/v2\/categories?post=1028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.spa-balance.com\/es\/wp-json\/wp\/v2\/tags?post=1028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}